Over the years, there have been very few medicines that have proven as potent and versatile as cannabidiol (CBD) has. The extract is one of the over 100 active components that occur naturally in the cannabis plants, and its medicinal qualities have taken the world by storm. Said to be effective against a host of diseases ranging from anxiety, high blood pressure, and depression to rare childhood epilepsies, CBD, and hemp by extension, has enjoyed significant booms in both demand and supply.
This was compounded by the 2018 Farm Bill, which legalized the cultivation of industrial hemp. In October, the USDA released further regulations to structure the sector, making it easier for hemp farmers and CBD processors to run their operations. This has resulted in an influx of CBD products, each claiming to be medically effective. Most of these products contain either CBD isolate or…
About CBDWire
CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.
To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CBDWire.com
Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer
Do you have a questions or are you interested in working with CNW? Ask Our Editor
CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
[email protected]
CBDWire is part of the InvestorBrandNetwork.